General MedicationsINTRAVENOUSGeneric
METHOTREXATE
METHOTREXATE
Standard Dose
5GM/50ML (100MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview METHOTREXATE is listed in Drugs@FDA under application 214121 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient METHOTREXATE Form and strength SOLUTION;INTRAVENOUS - 5GM/50ML (100MG/ML) Sponsor ACCORD HLTHCARE Submission history Latest submission status date: 2026-03-13 00:00:00.
Structured Monograph
Clinical summary
Approval overview METHOTREXATE is listed in Drugs@FDA under application 214121 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient METHOTREXATE Form and strength SOLUTION;INTRAVENOUS - 5GM/50ML (100MG/ML) Sponsor ACCORD HLTHCARE Submission history Latest submission status date: 2026-03-13 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.